CTOs on the Move

Defense Health Agency

www.health.mildha

 
The DHA is a joint, integrated Combat Support Agency that enables the Army, Navy, and Air Force medical services to provide a medically ready force and ready medical force to Combatant Commands in both peacetime and wartime. The DHA supports the delivery of integrated, affordable, and high quality health services to 9.5 million Military Health System beneficiaries and is responsible for driving greater integration of clinical and business processes across the MHS. The DHA oversees the delivery of health care services like the TRICARE Health Plan, pharmacy, public health, and health information technology. DHA carries out these operations using a ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.health.mildha
  • 7700 Arlington Boulevard Suite 5101
    Falls Church, VA USA 22042
  • Phone: 888.647.6676

Executives

Name Title Contact Details
Lisa Belter
Chief Technology Officer Profile

Similar Companies

China Aoxing Pharmaceutical Company

China Aoxing Pharmaceutical Company is a Jersey City, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Electromed Co

Electromed Co is a Walnut, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Occupational Environmental Health Solutions

Occupational Environmental Health Solutions is a Chatham, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Care Products Inc

Care Products Inc is a Waterbury, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Questcor

We are a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Our efforts are currently focused on the fields of neurology, nephrology and rheumatology, areas of medicine which have significant unmet medical needs. Our main product is H.P Acthar® Gel (repository corticotropin injection), a naturally-derived formulation of adrenocorticotropic hormones used in a variety of disorders having an inflammatory component. We are currently supporting research in a number of rare conditions, where there is significant unmet need for treatment alternatives to standard therapies. We are also actively supporting research efforts to better understand disease processes and therapeutic mechanisms of action in conditions where Acthar might potentially play a role in treatment.